Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa is a research paper published in medRxiv (2020). On theSindex it has a DataRank of 0.442. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.442
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Wellcome Trust
Grant: unidentified
unidentified
National Institutes of Health
Grant: 2T32AI052074-16A1
BU Clinical HIV/AIDS Research Training Program (BU-CHART
National Institutes of Health
Grant: 1K01MH119923-01A1
Using behavioral economics to improve the uptake of and persistence on pre-exposure prophylaxis in men who have sex with men to prevent HIV infection
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Could widespread use of antiviral treatment curb the COVID-19 pandemic? A modeling study
Additional file 1 of Could widespread use of antiviral treatment curb the COVID-19 pandemic? A modeling study